UK markets open in 5 hours 52 minutes

Gain Therapeutics, Inc. (GANX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.5000-0.0100 (-0.40%)
At close: 04:00PM EDT
2.4200 -0.08 (-3.20%)
After hours: 06:41PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-21,144
-22,268
-17,591
-13,891
-3,578
-
Depreciation & amortisation
84.865
83.579
64.168
15.484
9.592
-
Stock-based compensation
2,884
3,259
1,526
839.371
81.64
-
Change in working capital
401.568
442.23
1,515
-329.784
237.504
-
Accounts receivable
-
-
0
8.264
-0.196
-8.352
Accounts payable
-997.138
-643.164
1,067
-521.394
395.543
-
Other working capital
-18,239
-18,881
-14,811
-12,460
-3,261
-
Other non-cash items
-461.097
-383.188
-206.861
-34.135
-
1.278
Net cash provided by operating activities
-18,235
-18,866
-14,692
-12,366
-3,240
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-15.358
-118.953
-94.212
-20.826
-
Purchases of investments
0
-1,956
-17,735
0
-
-
Sales/maturities of investments
11,139
12,194
3,079
0
-
-
Net cash used for investing activities
11,134
10,223
-14,775
-94.212
-20.826
-
Cash flows from financing activities
Debt repayment
-90.327
-89.067
-78.774
-21.951
0
-
Common stock issued
11,960
12,730
0
42,630
0.177
-
Other financing activities
-
-
-
-853.488
-470.745
-
Net cash used provided by (used for) financing activities
11,747
12,641
-78.774
41,767
10,487
-
Net change in cash
4,654
4,487
-29,570
29,408
7,191
-
Cash at beginning of period
6,019
7,342
36,912
7,504
313.7
-
Cash at end of period
10,665
11,829
7,342
36,912
7,504
-
Free cash flow
Operating cash flow
-18,235
-18,866
-14,692
-12,366
-3,240
-
Capital expenditure
-
-15.358
-118.953
-94.212
-20.826
-
Free cash flow
-18,239
-18,881
-14,811
-12,460
-3,261
-